SNSE Past Earnings image   This SNSE past earnings page last updated 11/9/2022
SNSE Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/8/2022-0.440
Q2 20228/9/2022-0.340
Q1 20225/10/2022-0.400
Q4 20213/10/2022-0.300
Q3 202111/9/2021-0.320
Q2 20218/4/2021-0.320
Q1 20215/12/2021-0.420
SNSE Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/8/2022NA
Q2 20228/9/2022NA
Q1 20225/10/2022NA
Q4 20213/10/2022NA
Q3 202111/9/2021NA
Q2 20218/4/2021NA
Q1 20215/12/2021NA
Quotes delayed 20 minutes

Email EnvelopeFree SNSE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sensei Biotherapeutics (SNSE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SOLY Past Earnings
SONN Past Earnings
SPNE Past Earnings
SPPI Past Earnings
SPRB Past Earnings
SPRO Past Earnings
SQL Past Earnings
SQZ Past Earnings
SRDX Past Earnings
SRGA Past Earnings

SNSE Past Earnings Q&A

What was the best and worst SNSE past earnings results?
For Sensei Biotherapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest SNSE past earnings result in our data set was -0.300/share posted in Q4 2021, while the lowest was in Q3 2022 when SNSE posted -0.440/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when SNSE reported NA in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at NA of revenue.

  Suggested answer: There are 7 SNSE past earnings results in our data set.

On this page we presented the SNSE past earnings date information for Sensei Biotherapeutics. Reviewing that SNSE Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when SNSE posted gaap of -0.300/share. Meanwhile the lowest SNSE past earnings result was in Q3 2022, when SNSE posted gaap of -0.440/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when SNSE reported NA in revenue, while the smallest revenue quarter was Q3 2022 when SNSE reported NA in revenue.

Any self directed investor doing their due diligence on SNSE or any other given stock can benefit from researching all of the Sensei Biotherapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Sensei Biotherapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SNSE. Thanks for visiting, and the next time you need to research SNSE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: RDHL Options Chain, HONE Stock Predictions, FENX Price Target.

 

SNSE Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.